TorMagnus Pharmaceuticals Company

TorMagnus Pharmaceuticals is a drug discovery firm dedicated to discovering treatments for Peroxisomal disorders.


Investors

Funding Status: Seed
Industry: Medical BioTech
Technology: ['BioTech & HealthTech']
Headquarters: San Francisco, California, United States
Total Funding: 500000.0
Last Funding Date: 2023-04-05
Last Funding Type: Pre-Seed
Investor Type: contact@tormagnuspharma.com
Investors Number: 1.0
Founded Date: 2022-05-01